February 6th, 2019 – A leading dermatology center in Tennessee has commenced advanced skin radiotherapy treatments using the new RADiant treatment system from Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions.
Dr. Ken Takegami, MD., and his team at Adult and Pediatric Dermatology of Tullahoma, recently completed the treatment of his first patients on the RADiant dual modality radiotherapy system, expanding his non-melanoma skin cancer treatment options with a non-surgical alternative.
“I wanted to offer superficial radiotherapy for my older patients, many of whom are what I describe as ‘Mohs fatigued’”, says Dr. Takegami. “RADiant is an excellent non-surgical alternative to treat their non-melanoma skin cancer.”
RADiant is the latest innovative radiotherapy platform from Xstrahl, global leader in superficial therapeutic X-ray systems. The RADiant system is a small and compact unit specifically designed for use by dermatologists. Treatment delivery is fast, convenient and pain free. Patient visit time is kept to a minimum, typically 15 minutes including setup and treatment, leaving them free to continue with their normal daily activities. Advanced features such as illuminated halo applicators and an intuitive clinical interface provide physicians with meticulous control to deliver superior, surgical quality results.
“RADiant expands the dermatologists’ non-melanoma skin cancer treatment options with the latest dual modality radiotherapy technology,” says Adrian Treverton, CEO of Xstrahl. “RADiant offers an extremely effective treatment option for when Mohs is not available, or the patient is unsuitable for surgery.”